According to the enterprise research app, recently, Suzhou Xinhe Guoqing Phase II Venture Capital Partnership was established, with an investment amount of 185 million yuan. The business scope includes venture capital. Enterprise investigation and equity penetration showed that the partnership was jointly owned by Sino-Singapore Suzhou Industrial Park Venture Capital Co., Ltd. and Cinda Biopharmaceutical Co., Ltd.

According to the enterprise research app, recently, Suzhou Xinhe Guoqing Phase II Venture Capital Partnership was established, with an investment amount of 185 million yuan. The business scope includes venture capital. Enterprise investigation and equity penetration showed that the partnership was jointly owned by Sino-Singapore Suzhou Industrial Park Venture Capital Co., Ltd. and Cinda Biopharmaceutical Co., Ltd.